1-4 of 4
Carlos Buesa
Close
Sort by
Journal Articles

Iadademstat Combination with Azacitidine Is a Safe and Effective Treatment in First Line Acute Myeloid Leukemia. Final Results of the Alice Trial

Olga Salamero, Tim C.P Somervaille, Antonieta Molero, Evelyn Acuña-Cruz, Jose A. Perez-Simon, Rosa Coll, Montserrat Arnan, Brayan Merchan, Ana Perez, Isabel Cano, Rebeca Rodríguez-Veiga, Mabel Arevalo, Sonia Gutierrez, Carlos Buesa, Douglas V Faller, Francesc Bosch, Pau Montesinos
Journal: Blood
Blood (2022) 140 (Supplement 1): 1711–1713.
https://doi.org/10.1182/blood-2022-168945
Published: 2022
Journal Articles

Iadademstat in Combination with Azacitidine Generates Robust and Long Lasting Responses in AML Patients (ALICE Trial)

Olga Salamero, Tim C.P Somervaille, Antonieta Molero, Evelyn Acuña-Cruz, Jose Pérez-Simón, Rosa Coll, Montserrat Arnan Sangerman, Brayan Merchan, Ana Perez, Isabel Cano, Rebeca Rodríguez-Veiga, Sonia Gutierrez, Carlos Buesa, Francesc Bosch, Pau Montesinos
Journal: Blood
Blood (2021) 138 (Supplement 1): 3376.
https://doi.org/10.1182/blood-2021-152183
Published: 2021
Journal Articles

Robust Efficacy Signals in Elderly AML Patients Treated with Iadademstat in Combination with Azacitidine (ALICE Phase IIa Trial)

Olga Salamero, MD, Tim C.P Somervaille, PhD FRCP, FRCPath, Antonieta Molero, MD, Evelyn Acuña, MD, Ana Perez, MD, Isabel Cano, MD, Rebeca Rodríguez-Veiga, MD, Sonia Gutierrez, Roger Bullock, MD, Carlos Buesa, PhD, Francesc Bosch, MD PhD, Pau Montesinos, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22.
https://doi.org/10.1182/blood-2020-134310
Published: 2020
Journal Articles

Iadademstat Shows Efficacy in Elderly AML Patients in Combination with Azacitidine. Alice Trial

Carlos Buesa, PhD, Tim CP Somervaille, MD PhD, Mabel Arevalo, PhD, Jordi Xaus, PhD, Sonia Gutierrez, Roger Bullock, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3839.
https://doi.org/10.1182/blood-2019-125121
Published: 2019